Submissions are open for the upcoming issue.

Molecular Medicine Peer-reviewed scientific journal

Found: 4

ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2022 · pp. 25–32

COMPARATIVE STUDY OF THE SOLUBLE FORMS OF IMMUNE CHECKPOINT PROTEINS VISTA, PD-1, PD-L1, AND BONE HOMEOSTASIS REGULATOR RANKL IN BONE TUMOR PATIENTS

Background. Low sensitivity of bone tumors to various schemes of standard chemotherapy stimulated the search of new targets for their medicamentous treatment. Among such targets are the so-called “immune checkpoints” promoting the escape of the tumor from the …

10.29296/24999490-2022-06-04Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018

MATRIX METALLOPROTEINESES AND THEIR TISSUE INHIBITORS IN PRIMARY BONE TUMOR PATIENTS: CLINICAL AND PATHOLOGIC CORRELATIONS

Introduction. The search of molecular markers for early diagnostics, prognosis, and identification of new objects for molecular-targeted therapy of primary bone tumors remains one of the most important tasks despite the significant achievements in the treatmen…

10.29296/24999490-2018-05-08Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2016

RANK/RANKL/OPG SYSTEM COMPONENTS AND INTERLEUKINS 6, 8 16 IN BLOOD SERUM OF PATIENTS WITH PRIMARY BONE NEOPLASMS

Introduction. RANK/RANKL/OPG ligand-receptor system is a key player in bone tissue homeostasis directly regulating osteoclast differentiation and osteolysis. Many pathologic processes imposed by impairments in bone remodeling including tumor growth and metasta…

Details ↗
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2015

PROGNOSTIC SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTORS (IGF) AND IGF-BINDING PROTEINS LEVELS IN BONE SARCOMA PATIENTS

Introduction. Insulin-like growth factors (IGF) signaling system plays a major role in the development and progression of various sarcomas and other solid tumors, and therefore its components are regarded as promising diagnostic and prognostic tumor markers an…

Details ↗

Article search and quick navigation

Navigation